CDX2, CK7 and CK20 staining in distant metastases of | Download Table
CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
Diagnostics | Free Full-Text | CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses
CDX1 and CDX2 immunohistochemistry and image analysis at different... | Download Scientific Diagram
The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report | World Journal of Surgical Oncology | Full Text
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
CDX2 as a marker for intestinal differentiation: Its utility and limitations
Current Oncology | Free Full-Text | Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
JCI Insight - LIN28B induces a differentiation program through CDX2 in colon cancer
CDX2 - TSGP | PathnSitu Biotechnologies
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | Cellular Oncology
Gastric-immunophenotype tumour end with CDX2 expression. Tumour cells... | Download Scientific Diagram
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - ScienceDirect
CDX2 (a, b) MUC2 (c, d) immunostaining patterns: a strong nuclear CDX2... | Download Scientific Diagram
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts | British Journal of Cancer
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink
CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research
Pathology Outlines - CDX2
CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer - ScienceDirect
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
